| Rein Houben
Rein leads the development and implementation of TIME. His background is in TB epidemiology, with a broad interest in applying mathematical modelling methods to inform policy decisions, and address questions on TB natural history and epidemiology.
He also provides epidemiological support for the TB Modelling and Analysis Consortium (TB MAC) .
| Marek Lalli
Marek’s focus is developing components of the TIME model and its in-country application. He provides epidemiological support to National TB Programmes throughout the programming cycle and plays a key role in the country dialogue process. He models interventions from National Strategic Plans in TIME Impact to generate short and long-term projections of the TB epidemic and provides recommendations for discussion amongst stakeholders.
| Debora Pedrazzoli
Debora provides epidemiological and mathematical modelling support to countries during their submission to the Global Fund under the ‘New Funding Model’, by applying and developing the TIME model. She leads the development of TIME Economics, a module in TIME which is intended to address TB-specific allocative efficiency and cost-effectiveness questions.
Debora’s primary interest is in the socio-economic epidemiology of TB. Her research focuses on modelling the impact of social and structural drivers on TB epidemiology, and in evaluating interventions to address TB and social inequalities.
| Kristian Godfrey
Kristian has previously worked at Open Society Foundation, the Australian Red Cross and The Liverpool School of Tropical Medicine before joining the TIME team as USAID Project Coordinator in March 2015. His background is in project management and administration in international development settings.
| Richard White
Richard advises the TIME team. He has over 15 years experience working as in infectious disease modelling, particularity TB and HIV.
| Tom Sumner
Tom’s research focuses on the use of models to predict and understand the impact of interventions with a particular focus on TB preventive therapy.